Learn More
Description
Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq
Specifications
Specifications
| Antigen | BLMH |
| Applications | ELISA, Western Blot |
| Classification | Monoclonal |
| Clone | 4A2 |
| Conjugate | Unconjugated |
| Description | Mouse monoclonal antibody raised against a partial recombinant BLMH. |
| Formulation | PBS with no preservative; pH 7.4 |
| Gene | BLMH |
| Gene Accession No. | NM_000386 |
| Gene Alias | BH/BMH |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.